Keithly  Garnett net worth and biography

Keithly Garnett Biography and Net Worth

Keithly Garnett has served as NeOnc Technologies Holdings, Inc.’s Chief Financial Officer since April 2023 and director since January 2023. Mr. Garnett spent over 17 years with Ernst & Young LLP in their Transaction Advisory Services practice. During that time, he specialized in business valuation modelling and strategy. His services were provided in support of audit-related work for financial reporting, tax planning, and management planning.

His client list included companies such as Amgen, Edwards Life Sciences, Medtronic, etc. In any given year, he led over 50 transaction analyses and/or reviews for publicly traded companies, in connection with their SEC financial reporting requirements.

From March 2017 to January 2023, Mr. Garnett was a Director at Sycamore Valuation. Since January 2021, Mr. Garnett has worked as the Chief Financial Officer of AFH Holding & Advisory, a single-member family office based in Malibu.

From 2018 to 2022, he was involved with the Shuttle Pharmaceutical Holdings public offering, which was successfully listed on the Nasdaq in 2022.

Mr. Garnett holds a Master’s in Business Administration with a concentration in Corporate Financial Management and a Bachelor of Science degree in Business Management. He also completed the Columbia University Executive Education program with a certificate from the Chief Financial Officer program.

What is Keithly Garnett's net worth?

The estimated net worth of Keithly Garnett is at least $644.67 thousand as of September 14th, 2026. Mr. Garnett owns 242,357 shares of Neonc Technologies stock worth more than $644,670 as of October 15th. This net worth approximation does not reflect any other assets that Mr. Garnett may own. Learn More about Keithly Garnett's net worth.

How do I contact Keithly Garnett?

The corporate mailing address for Mr. Garnett and other Neonc Technologies executives is 23975 Park Sorrento, Suite 205, Calabasas, CA, 91302. Neonc Technologies can also be reached via phone at 310-663-7831. Learn More on Keithly Garnett's contact information.

Has Keithly Garnett been buying or selling shares of Neonc Technologies?

Keithly Garnett has not been actively trading shares of Neonc Technologies over the course of the past ninety days. Most recently, on Monday, September 14th, Keithly Garnett bought 257 shares of Neonc Technologies stock. The stock was acquired at an average cost of $3.89 per share, with a total value of $999.73. Following the completion of the transaction, the chief financial officer now directly owns 242,357 shares of the company's stock, valued at $942,768.73. Learn More on Keithly Garnett's trading history.

Who are Neonc Technologies' active insiders?

Neonc Technologies' insider roster includes Jim Delshad (Director), Keithly Garnett (CFO), and Amir Heshmatpour (CEO, Executive Chairman, and President). Learn More on Neonc Technologies' active insiders.

Are insiders buying or selling shares of Neonc Technologies?

In the last twelve months, Neonc Technologies insiders bought shares 23 times. They purchased a total of 246,612 shares worth more than $1,145,838.28. The most recent insider tranaction occured on September, 15th when CEO Amir F. Heshmatpour bought 35,000 shares worth more than $115,500.00. Learn More about insider trades at Neonc Technologies.

Information on this page was last updated on 9/15/2026.

Keithly Garnett Insider Trading History at Neonc Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/14/2026Buy257$3.89$999.73242,357View SEC Filing Icon  
5/22/2025Buy675$7.29$4,920.75240,900View SEC Filing Icon  
5/19/2025Buy135$7.23$976.05240,225View SEC Filing Icon  
4/15/2025Buy300$5.38$1,614.00241,200View SEC Filing Icon  
See Full Table

Keithly Garnett Buying and Selling Activity at Neonc Technologies

This chart shows Keithly Garnett's buying and selling at Neonc Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neonc Technologies Company Overview

Neonc Technologies logo
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Read More

Today's Range

Now: $2.73
Low: $2.85
High: $2.85

50 Day Range

MA: $3.78
Low: $2.53
High: $5.53

2 Week Range

Now: $2.73
Low: $2.50
High: $12.00

Volume

466 shs

Average Volume

112,617 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A